Wooridul Huebrain Limited

KSE 118000.KS

Wooridul Huebrain Limited Receivables for the year ending December 31, 2023: USD 9.51 M

Wooridul Huebrain Limited Receivables is USD 9.51 M for the year ending December 31, 2023, a -54.15% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Wooridul Huebrain Limited Receivables for the year ending December 31, 2022 was USD 20.74 M, a 27.19% change year over year.
Wooridul Huebrain Limited Receivables for the year ending December 31, 2021 was USD 16.31 M, a 44.11% change year over year.
Wooridul Huebrain Limited Receivables for the year ending December 31, 2020 was USD 11.32 M, a 5.87% change year over year.
Wooridul Huebrain Limited Receivables for the year ending December 31, 2019 was USD 10.69 M, a 4.20% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

KSE: 118000.KS

Wooridul Huebrain Limited

CEO	Ms. Soo-Kyung Kim
IPO Date	May 5, 2006
Location	South Korea
Headquarters	156, No. 202, Dream Building)
Employees	23
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Cosmetics Dental Care Hardware & Electronics Medical Instruments Personal Care Pharmaceuticals

Description

Wooridul Huebrain Limited engages in the medical, life and health, pharmaceutical, and storage businesses. It sells medical equipment and appliances, health equipment, medicines, and computer servers. Wooridul Huebrain Limited was formerly known as Wooridul Life Sciences Limited and changed its name to Wooridul Huebrain Limited in April 2014. Wooridul Huebrain Limited was founded in 2009 and is based in Seoul, South Korea.

Key trends

Past 5 years